Disparities in Use of Immunotherapies Persist After FDA Approval
Some disparities that existed before FDA approval persisted after approval, and some new disparities emerged after FDA approval.
Diagnosis & Disease Information
Many Immune Checkpoint Inhibitor Combination Therapies Show No Evidence of Drug Synergy
The efficacy of many combination therapies may be due to independent drug action, not synergistic or additive effects.
Cancer Rates High Among Long-Term Kidney Transplant Recipients
Cancer incidence is relatively high among kidney transplant recipients with allograft survival times longer than 20 years.
Guidance Issued for Preventing Cutaneous SCC in Solid Organ Recipients
For 5 of 6 actinic damage and skin cancer index stages, consensus-based recommendations developed
Five Neutrogena and Aveeno Spray Sunscreens Recalled Due to Benzene
Johnson & Johnson said it was still investigating how traces of benzene were discovered in the sunscreens
Therapeutic Advancements Have Facilitated Surgery Optimization, ASCO Officials Report
ASCO outlined advances in oncology that were the most clinically meaningful or had the biggest scientific impact from October 2018 through September 2019.
Longer Duration of Steroids May Affect Outcomes During Anti-PD-1 Treatment
The use of steroids for the treatment of immune-related adverse events may have survival consequences.
Sun Defenses Up in Transplant Patients After Skin Cancer Study
Increased odds of using multiple sun protection measures among organ transplant recipients.
Skin Cancer After Organ Transplant Declining
Standardized incidence ratio peaked in patients who underwent transplantation in 1983-1987 period.
Melanoma Staging System Updated
Key changes include new N category descriptors, more stage III subgroups, new M1D designation.
- Loading...
Loading...
Next post in Transplantation
Loading... 
Loading...